229 filings
Page 8 of 12
8-K
gkewy qfb
26 May 11
Other Events
12:00am
8-K
ou9n47w
20 May 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
e6kaj8ra9m2
6 May 11
Rigel Assumes Development Responsibility for Inhaled Asthma Therapy
12:00am
8-K
a14e0y
3 May 11
Rigel Announces First Quarter Financial Results
12:00am
8-K
mi90jl23z2 9mlzr
1 Mar 11
Rigel Announces Fourth Quarter and Year End 2010 Financial Results
12:00am
8-K
jz2j 5yzwn
9 Feb 11
Departure of Directors or Certain Officers
12:00am
8-K
kf1qy0m96t1n fefy641
17 Dec 10
Departure of Directors or Certain Officers
12:00am
8-K
m272i70z1qj
2 Nov 10
Rigel Announces Third Quarter 2010 Financial Results
12:00am
8-K
z029vuw1ko50hp
3 Aug 10
Rigel Announces Second Quarter 2010 Financial Results
12:00am
8-K
15yw171aoo 7u2
1 Jun 10
Rigel Pharmaceuticals Names Raul Rodriguez President
12:00am
8-K
jrm m222ufa16l
4 May 10
Rigel Announces First Quarter 2010 Financial Results
12:00am
8-K
j2e8xmv2yi
2 Mar 10
Rigel Announces Fourth Quarter and Year End 2009 Financial Results
12:00am
8-K
82kbacqo5y12erfa3 8x
18 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
o70dxyw
3 Nov 09
Rigel Announces Third Quarter 2009 Financial Results
12:00am
8-K/A
rgnma bun6rz7p4jl8rw
18 Sep 09
Financial Statements and Exhibits
12:00am
8-K
gfsw6r2xl84qt
17 Sep 09
Other Events
12:00am
8-K
90cmq69zf6z8
4 Aug 09
Rigel Announces Second Quarter 2009 Financial Results
12:00am
8-K
au046
24 Jul 09
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies — Results Incongruent
12:00am
8-K
b46c0du7gfrux46tw
9 Jul 09
Rigel’s R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
12:00am
8-K
r7lv mhnl7
5 May 09
Rigel Announces First Quarter 2009 Financial Results
12:00am